Literature DB >> 18381127

Histone deacetylase inhibitors: a novel class of anti-cancer agents on its way to the market.

Matthias Körner1, Ulrich Tibes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381127     DOI: 10.1016/S0079-6468(07)00005-7

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN: 0079-6468


× No keyword cloud information.
  5 in total

1.  Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes.

Authors:  Raghupathi Neelarapu; Denise L Holzle; Subash Velaparthi; He Bai; Michael Brunsteiner; Sylvie Y Blond; Pavel A Petukhov
Journal:  J Med Chem       Date:  2011-06-02       Impact factor: 7.446

2.  Beyond picomolar affinities: quantitative aspects of noncovalent and covalent binding of drugs to proteins.

Authors:  Adam J T Smith; Xiyun Zhang; Andrew G Leach; K N Houk
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

3.  Binding ensemble profiling with photoaffinity labeling (BEProFL) approach: mapping the binding poses of HDAC8 inhibitors.

Authors:  Bai He; Subash Velaparthi; Gilles Pieffet; Chris Pennington; Aruna Mahesh; Denise L Holzle; Michael Brunsteiner; Richard van Breemen; Sylvie Y Blond; Pavel A Petukhov
Journal:  J Med Chem       Date:  2009-11-26       Impact factor: 7.446

4.  Novel hybrid molecule overcomes the limited response of solid tumours to HDAC inhibitors via suppressing JAK1-STAT3-BCL2 signalling.

Authors:  Zhi Huang; Wei Zhou; Yongtao Li; Mei Cao; Tianqi Wang; Yakun Ma; Qingxiang Guo; Xin Wang; Chao Zhang; Chenglan Zhang; Wenzhi Shen; Yanhua Liu; Yanan Chen; Jianyu Zheng; Shengyong Yang; Yan Fan; Rong Xiang
Journal:  Theranostics       Date:  2018-10-05       Impact factor: 11.556

5.  In search of constrained FTY720 and phytosphingosine analogs as dual acting anticancer agents targeting metabolic and epigenetic pathways.

Authors:  Jean-Baptiste Garsi; Lorenzo Sernissi; Vito Vece; Stephen Hanessian; Alison N McCracken; Grigor Simitian; Aimee L Edinger
Journal:  Eur J Med Chem       Date:  2018-09-21       Impact factor: 6.514

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.